MEITY

Spotlight

COVID-19: Government To Conduct Randomised Controlled Clinical Trial Of Ashwagandha

May 8, 2020 13:01
Healthwire Bureau

New Delhi: The government will conduct a randomised controlled clinical trial to assess the efficacy of ayurvedic drug ashwagandha as a preventive intervention among healthcare professionals and high-risk COVID-19 population…

View Post

Menu

MEITY

COVID-19: Government To Conduct Randomised Controlled Clinical Trial Of Ashwagandha

Vinod Kambli Admitted To Hospital In Maharshtra, Condition Critical

Diabetes and Inflammation Linked to Accelerated Brain Aging and Higher Dementia Risk: Experts

Heart Muscle Regeneration Observed in Patients with Artificial Hearts, Study Finds

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial